Survival Analysis meets Counterfactual Inference
share
There is growing interest in applying machine learning methods for counterfactual inference from observational data. However, approaches that account for survival outcomes are relatively limited. Survival data are frequently encountered across diverse medical applications, i.e., drug development, risk profiling, and clinical trials, and such data are also relevant in fields like manufacturing (for equipment monitoring). When the outcome of interest is time-to-event, special precautions for handling censored events need to be taken, as ignoring censored outcomes may lead to biased estimates. We propose a theoretically grounded unified framework for counterfactual inference applicable to survival outcomes. Further, we formulate a nonparametric hazard ratio metric for evaluating average and individualized treatment effects. Experimental results on real-world and semi-synthetic datasets, the latter which we introduce, demonstrate that the proposed approach significantly outperforms competitive alternatives in both survival-outcome predictions and treatment-effect estimation.
READ FULL TEXT
